TW275068B - - Google Patents

Info

Publication number
TW275068B
TW275068B TW082110137A TW82110137A TW275068B TW 275068 B TW275068 B TW 275068B TW 082110137 A TW082110137 A TW 082110137A TW 82110137 A TW82110137 A TW 82110137A TW 275068 B TW275068 B TW 275068B
Authority
TW
Taiwan
Prior art keywords
analogues
residues
heparin binding
growth factor
binding site
Prior art date
Application number
TW082110137A
Other languages
English (en)
Chinese (zh)
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of TW275068B publication Critical patent/TW275068B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/50Fibroblast growth factor [FGF]
    • C07K14/503Fibroblast growth factor [FGF] basic FGF [bFGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
TW082110137A 1993-09-24 1993-12-01 TW275068B (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12697493A 1993-09-24 1993-09-24

Publications (1)

Publication Number Publication Date
TW275068B true TW275068B (https=) 1996-05-01

Family

ID=22427669

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082110137A TW275068B (https=) 1993-09-24 1993-12-01

Country Status (13)

Country Link
EP (1) EP0645451B1 (https=)
JP (1) JPH07149797A (https=)
KR (1) KR100320803B1 (https=)
AT (1) ATE204604T1 (https=)
AU (1) AU680533B2 (https=)
CA (1) CA2132668A1 (https=)
DE (1) DE69428013T2 (https=)
DK (1) DK0645451T3 (https=)
ES (1) ES2161233T3 (https=)
NZ (1) NZ264529A (https=)
PT (1) PT645451E (https=)
TW (1) TW275068B (https=)
ZA (1) ZA947454B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874565A (en) 1995-08-29 1999-02-23 Washington University Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
US7049428B1 (en) 1998-03-04 2006-05-23 Washington University HCV variants
AU3170499A (en) * 1998-04-28 1999-11-16 Eisai Co. Ltd. Fibroblast growth factor mutein compositions and methods of use therefor
CA2796459C (en) 2010-04-16 2016-05-24 Salk Institute For Biological Studies Methods for treating metabolic disorders using fgf-1
US9475856B2 (en) 2012-03-02 2016-10-25 New York University Chimeric FGF21 proteins with enhanced binding affinity for β-klotho for the treatment of type II diabetes, obesity, and related metabolic disorders
US9474785B2 (en) 2012-06-07 2016-10-25 New York University Chimeric fibroblast growth factor 19 proteins and methods of use
US9657075B2 (en) 2012-06-07 2017-05-23 New York University Chimeric fibroblast growth factor 23 proteins and methods of use
US9464126B2 (en) * 2012-06-07 2016-10-11 New York University Chimeric fibroblast growth factor 21 proteins and methods of use
US9550820B2 (en) 2013-02-22 2017-01-24 New York University Chimeric fibroblast growth factor 23/fibroblast growth factor 19 proteins and methods of use
WO2015061331A1 (en) 2013-10-21 2015-04-30 Salk Institute For Biological Studies Chimeric fibroblast growth factor (fgf) 2/fgf1 peptides and methods of use
AU2014340241B2 (en) 2013-10-21 2018-11-01 Salk Institute For Biological Studies Mutated fibroblast growth factor (FGF) 1 and methods of use
WO2017075260A1 (en) 2015-10-30 2017-05-04 Salk Institute For Biological Studies Treatment of steroid-induced hyperglycemia with fibroblast growth factor (fgf) 1 analogs
WO2017159943A1 (ko) * 2016-03-17 2017-09-21 중앙대학교 산학협력단 화학반응을 통하여 결합된 섬유아세포 증식인자-헤파린 복합체 및 이의 제조 방법
US11229681B2 (en) * 2017-07-14 2022-01-25 The Regents Of The University Of California Dominant-negative FGF2 antagonists
US11542309B2 (en) 2019-07-31 2023-01-03 Salk Institute For Biological Studies Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose
CN116042681A (zh) * 2022-08-01 2023-05-02 普纳思细胞(厦门)生物科技有限公司 一种bFGF热稳定性改造的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0377579A1 (en) * 1987-07-07 1990-07-18 California Biotechnology, Inc. Recombinant fibroblast growth factors
WO1989004832A1 (en) * 1987-11-24 1989-06-01 Amgen Inc. Analogs of fibroblast growth factor
GB8821795D0 (en) * 1988-09-16 1988-10-19 Erba Carlo Spa New derivatives of human/bovine basic fibroplast growth factor

Also Published As

Publication number Publication date
AU680533B2 (en) 1997-07-31
EP0645451A1 (en) 1995-03-29
DK0645451T3 (da) 2001-10-08
ATE204604T1 (de) 2001-09-15
PT645451E (pt) 2001-12-28
DE69428013T2 (de) 2002-05-29
EP0645451B1 (en) 2001-08-22
KR100320803B1 (ko) 2002-06-20
ES2161233T3 (es) 2001-12-01
NZ264529A (en) 1997-06-24
JPH07149797A (ja) 1995-06-13
CA2132668A1 (en) 1995-03-25
DE69428013D1 (de) 2001-09-27
ZA947454B (en) 1995-05-15
AU7418594A (en) 1995-04-06

Similar Documents

Publication Publication Date Title
TW275068B (https=)
EP0246753A3 (en) Fibroblast growth factor antagonists
DE69001139D1 (de) Hueftgelenkspfanne mit zwei radien.
DE69011793D1 (de) Kollagenpulver mit guter Dispersionsstabilität und Verwendung als lederähnliche oberflächliche Beschichtung.
DE69019578D1 (de) Baustahl mit hoher Festigkeit und guter Bruchzähigkeit.
JPS6420096A (en) Mutein and its production
DE68916512D1 (de) Zusammensetzung zur Verminderung von postoperativen Adhäsionen und ihre Verwendung.
EP0286438A3 (en) Tapered i-beam surgical needles
DE59104156D1 (de) Höhenverstellbarer Tisch mit einer Linear- oder Geradführung.
NO910591L (no) Lavtaps, analog faseforskyver med nesten 360 grader faseforskyvning i x-baandet.
ATE129082T1 (de) Anordnung zur zusammenarbeitende wiederverteilung der aufgaben in einem mehrprozessoren-system.
GB8821795D0 (en) New derivatives of human/bovine basic fibroplast growth factor
DE69718359D1 (de) Verankerungsschaft, insbesondere zur Verwendung in Prothesen
ATE279965T1 (de) Gleitbrett
ATE263866T1 (de) Brückenlager
EP0336779A3 (en) Polypeptides stabilized by covalent hydrogen bond replacements
WO2000010426A3 (de) Tisch mit verschwenkbarer tischplatte
ES2016960B3 (es) Hidrociclon o piezas de hidrociclon, asi como procedimiento para su fabricacion
BE905894A (fr) Commutateur d'installation avec deux positions de commande mutuellement opposees.
SE8702813L (sv) Ortos
Ranu Application of Carbon Fibres in Orthopaedic Surgery
Cooper et al. Improvements in Prostheses
Kurth UHMWPE as a Biomaterial--Characterization With Gel-Permeation-Chromatography
Tribastone et al. Bituminous Composition and Its Use in the Water-Proofing Sector
IT8530742V0 (it) Snodo oscillante, particolarmente per tavoli allungabile con piani ausiliari ribaltabili.